AAAAAA
Results:
1-14
|
Results: 14
Authors:
Proctor, SJ
Taylor, PRA
Angus, B
Wood, K
Lennard, AL
Lucraft, H
Carey, PJ
Stark, A
Iqbal, A
Haynes, A
Russel, N
Leonard, RCF
Culligan, D
Conn, J
Jackson, GH
Citation: Sj. Proctor et al., High-dose ifosfamide in combination with etoposide and epirubicin (IVE) inthe treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy, EUR J HAEMA, 66, 2001, pp. 28-32
Authors:
Lennard, AL
Jackson, GH
Citation: Al. Lennard et Gh. Jackson, Stem cell transplantation, WEST J MED, 175(1), 2001, pp. 42-46
Authors:
Wells, AW
Bown, N
Reid, MM
Hamilton, PJ
Jackson, GH
Taylor, PR
Citation: Aw. Wells et al., Erythroleukaemia in the north of England: a population based study, J CLIN PATH, 54(8), 2001, pp. 608-612
Authors:
Cullup, H
Dickinson, AM
Jackson, GH
Taylor, PR
Cavet, J
Middleton, PG
Citation: H. Cullup et al., Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants, BR J HAEM, 113(3), 2001, pp. 807-813
Authors:
Cavet, J
Dickinson, AM
Norden, J
Taylor, PRA
Jackson, GH
Middleton, PG
Citation: J. Cavet et al., Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation, BLOOD, 98(5), 2001, pp. 1594-1600
Authors:
Jackson, GH
Angus, B
Carey, PJ
Finney, RD
Galloway, MJ
Goff, DK
Haynes, A
Lennard, AL
Leonard, RCF
McQuaker, IG
Proctor, SJ
Russell, N
Windebank, K
Taylor, PRA
Citation: Gh. Jackson et al., High dose ifosfamide in combination with etoposide and epirubicin followedby autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy, LEUK LYMPH, 37(5-6), 2000, pp. 561-570
Authors:
Lennard, AL
Jackson, GH
Citation: Al. Lennard et Gh. Jackson, Science, medicine, and the future: Stem cell transplantation (vol 321, pg 433, 2000), BR MED J, 321(7272), 2000, pp. 1331-1331
Authors:
Lennard, AL
Jackson, GH
Citation: Al. Lennard et Gh. Jackson, Science, medicine, and the future - Stem cell transplantation, BR MED J, 321(7258), 2000, pp. 433-437
Authors:
Taylor, PRA
Jackson, GH
Galloway, MJ
Soukop, M
Tinegate, H
Angus, B
Proctor, SJ
Citation: Pra. Taylor et al., Primary treatment of low-grade non-Hodgkin's lymphoma using an all oral anthracycline-containing regimen, chlorambucil, idarubicin, dexamethasone (CID) - a phase II study, CANC CHEMOT, 46(1), 2000, pp. 63-68
Authors:
Cavet, J
Lennard, A
Gascoigne, A
Finney, RD
Lucraft, HH
Richardson, C
Taylor, PRA
Proctor, SJ
Jackson, GH
Citation: J. Cavet et al., Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemia, BONE MAR TR, 25(5), 2000, pp. 571-573
Authors:
Wang, XN
Taylor, PRA
Skinner, R
Jackson, GH
Proctor, SJ
Hedley, D
Dickinson, AM
Citation: Xn. Wang et al., T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation, TRANSPLANT, 70(3), 2000, pp. 488-493
Authors:
Lucraft, HH
Taylor, PR
Jackson, GH
Lennard, AL
Proctor, SJ
Citation: Hh. Lucraft et al., Comments on: Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease, Tsang, et al. Eur J Cancer 1999, 35, 73-78, EUR J CANC, 35(10), 1999, pp. 1551-1551
Authors:
Pavlostathis, SG
Jackson, GH
Citation: Sg. Pavlostathis et Gh. Jackson, Biotransformation of 2,4,6-trinitrotoluene in Anabaena sp. cultures, ENV TOX CH, 18(3), 1999, pp. 412-419
Authors:
Dickinson, AM
Hromadnikova, I
Sviland, L
Jackson, GH
Taylor, PRA
Vavrinec, J
Sedlacek, P
Cermakova, M
Stary, J
Vitek, A
Sajdova, J
Proctor, SJ
Citation: Am. Dickinson et al., Use of a skin explant model for predicting GVHD in HLA-matched bone marrowtransplants - effect of GVHD prophylaxis, BONE MAR TR, 24(8), 1999, pp. 857-863
Risultati:
1-14
|